- Home
- Publications
- Publication Search
- Publication Details
Title
Cross-protection against drifted influenza viruses
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 9, Issue 3, Pages 582-590
Publisher
Informa UK Limited
Online
2013-01-26
DOI
10.4161/hv.23239
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhancement of DNA Vaccine Potency through Coadministration of CIITA DNA with DNA Vaccines via Gene Gun
- (2014) D. Kim et al. JOURNAL OF IMMUNOLOGY
- Acceptance and Safety of the Intradermal Influenza Vaccine Among the Elderly in Italy: an On-Field National Study
- (2012) Paolo Durando et al. ADVANCES IN THERAPY
- Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern Italy
- (2012) S. Mannino et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Influenza Virus H5 DNA Vaccination Is Immunogenic by Intramuscular and Intradermal Routes in Humans
- (2012) J. E. Ledgerwood et al. Clinical and Vaccine Immunology
- A Sentinel Platform to Evaluate Influenza Vaccine Effectiveness and New Variant Circulation, Canada 2010–2011 Season
- (2012) Danuta M. Skowronski et al. CLINICAL INFECTIOUS DISEASES
- The future of human DNA vaccines
- (2012) Lei Li et al. JOURNAL OF BIOTECHNOLOGY
- Direct Comparison of an Inactivated Subvirion Influenza A Virus Subtype H5N1 Vaccine Administered by the Intradermal and Intramuscular Routes
- (2012) S. M. Patel et al. JOURNAL OF INFECTIOUS DISEASES
- Intanza® 15mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses
- (2012) Filippo Ansaldi et al. VACCINE
- Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin
- (2012) Xiaoyu Liu et al. VACCINE
- Induction of a cross-reactive antibody response to influenza virus M2 antigen in pigs by using a Sendai virus vector
- (2012) Hirokazu Hikono et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system
- (2012) Giancarlo Icardi et al. Human Vaccines & Immunotherapeutics
- MAVS Forms Functional Prion-like Aggregates to Activate and Propagate Antiviral Innate Immune Response
- (2011) Fajian Hou et al. CELL
- Fluzone®Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults
- (2011) Filippo Ansaldi et al. Expert Review of Vaccines
- Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults
- (2011) Robert W. Frenck et al. VACCINE
- Immunogenicity of Three Different Influenza Vaccines against Homologous and Heterologous Strains in Nursing Home Elderly Residents
- (2010) Vincenzo Baldo et al. Clinical & Developmental Immunology
- MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk
- (2010) Paolo Durando et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18–60 years: Randomized, controlled, Phase III trial
- (2010) Robert Arnou et al. Human vaccines & immunotherapeutics
- Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations
- (2010) A. D. Cristillo et al. JOURNAL OF GENERAL VIROLOGY
- Coexpressed RIG-I Agonist Enhances Humoral Immune Response to Influenza Virus DNA Vaccine
- (2010) J. M. Luke et al. JOURNAL OF VIROLOGY
- Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination
- (2010) C.-J. Wei et al. SCIENCE
- Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus
- (2010) S. Khurana et al. Science Translational Medicine
- Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates
- (2010) Filippo Ansaldi et al. VACCINE
- Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant
- (2009) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Eleven years of Inflexal® V—a virosomal adjuvanted influenza vaccine
- (2009) Christian Herzog et al. VACCINE
- Immunogenicity and tolerability of an AS03A-adjuvanted prepandemic influenza vaccine: A phase III study in a large population of Asian adults
- (2009) Daniel Wai-Sing Chu et al. VACCINE
- Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: The importance of cross-protection
- (2009) Filippo Ansaldi et al. VACCINE
- MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination
- (2009) T. Vesikari et al. VACCINE
- Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults
- (2009) Tino F. Schwarz et al. VACCINE
- Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: Preliminary report of an observer-blind, randomised trial
- (2009) François Roman et al. VACCINE
- Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study
- (2009) Isabel Leroux-Roels et al. VACCINE
- Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice
- (2008) Jean-François Nicolas et al. Expert Review of Vaccines
- Intradermal Influenza Vaccine Administered Using a New Microinjection System Produces Superior Immunogenicity in Elderly Adults: A Randomized Controlled Trial
- (2008) David Holland et al. JOURNAL OF INFECTIOUS DISEASES
- Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine
- (2008) Isabel Leroux-Roels et al. PLoS One
- Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial
- (2008) Hans C. Rümke et al. VACCINE
- Safety of MF59™ adjuvant
- (2008) Viola Schultze et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search